XML 26 R17.htm IDEA: XBRL DOCUMENT v3.20.2
EQUITY INVESTMENT AND ROYALTIES (Narrative) (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 29, 2020
Sep. 30, 2020
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of equity investment   $ 680,941 $ 680,941
Cell MedX Corp. [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Amount of retained royalty on future sales $ 507,000    
Number of warrants issued 2,000,000 2,000,000 2,000,000
Term of warrant   3 years 3 years
Fair value of equity investment   $ 680,941 $ 680,941
Market price   $ 0.43 $ 0.43
Initial recognition of equity investment     $ 351,134
Gain (loss) on warrants revalued   $ (320,600) $ 329,807
Cell MedX Corp. [Member] | Warrant exercise Price 0.50 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of warrants issued 1,000,000    
Warrant exercise price $ 0.50    
Cell MedX Corp. [Member] | Warrant exercise Price 1.00 [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of warrants issued 1,000,000    
Warrant exercise price $ 1.00